Nykredit A S Purchases New Holdings in Humana Inc. $HUM

Nykredit A S purchased a new stake in Humana Inc. (NYSE:HUM) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 34,503 shares of the insurance provider’s stock, valued at approximately $13,705,000.

Other hedge funds also recently modified their holdings of the company. Revolve Wealth Partners LLC bought a new stake in shares of Humana during the fourth quarter valued at approximately $202,000. Woodline Partners LP lifted its position in Humana by 460.0% in the first quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock worth $2,697,000 after purchasing an additional 8,372 shares during the period. Sivia Capital Partners LLC lifted its position in Humana by 53.7% in the second quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock worth $316,000 after purchasing an additional 452 shares during the period. Cresset Asset Management LLC boosted its stake in Humana by 10.3% during the second quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock worth $581,000 after buying an additional 222 shares in the last quarter. Finally, WINTON GROUP Ltd increased its holdings in Humana by 58.5% in the 2nd quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock valued at $582,000 after buying an additional 879 shares during the period. Institutional investors own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on HUM shares. Raymond James Financial cut shares of Humana from an “outperform” rating to a “market perform” rating in a research note on Thursday, July 30th. Piper Sandler upgraded shares of Humana from a “hold” rating to an “overweight” rating and set a $463.00 price target on the stock in a research report on Thursday, July 30th. Leerink Partners upgraded Humana from a “market perform” rating to an “outperform” rating and set a $513.00 target price on the stock in a report on Thursday, July 30th. Seaport Research Partners lowered shares of Humana to a “neutral” rating in a report on Wednesday, May 20th. Finally, Wells Fargo & Company raised Humana from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $227.00 to $502.00 in a report on Monday, July 13th. Fourteen equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $403.91.

Humana Price Performance

Shares of HUM opened at $400.70 on Friday. The firm has a market capitalization of $48.12 billion, a PE ratio of 37.91, a P/E/G ratio of 2.67 and a beta of 0.74. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $428.88. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. The stock has a 50 day simple moving average of $388.44 and a 200 day simple moving average of $296.00.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. The business had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The firm’s quarterly revenue was up 26.2% on a year-over-year basis. During the same period last year, the business posted $6.27 earnings per share. Sell-side analysts predict that Humana Inc. will post 9 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 27th. Shareholders of record on Friday, October 30th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, October 30th. This represents a $3.54 annualized dividend and a yield of 0.9%. Humana’s payout ratio is 33.49%.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.